We offer Illumina microarray processing and expertise accessible to both internal and external researchers. If you would like to discuss your assays or enquire about costs and scheduling, please ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Late last year, Illumina discontinued its microRNA microarrays, the better to focus on sequencing. Cost should no longer keep researchers away from deep sequencing, says Shawn Baker, market ...

Kevin Gunderson and colleagues at Illumina in San Diego recently developed a whole-genome genotyping assay that bypasses PCR's multiplexing issues, using a single-tube amplification reaction combined ...

Illumina, Inc. engages in the development ... Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting.

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Manufacturer and investor interest may also protect the array market. As Illumina and ABI both have microarray products, it doesn't make sense for them to cannibalize their existing markets with ...